Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / November / The Real Risk of AI Isn’t Obsolescence – It’s Losing Ourselves
Digital and computational pathology Technology and innovation Laboratory management Opinion and Personal Narratives Professional Development Career Pathways Voices in the Community

The Real Risk of AI Isn’t Obsolescence – It’s Losing Ourselves

Can technology make pathology more human, or will it strip away what gives it meaning?

By Alae Kawam 11/24/2025 Opinion 3 min read

Share

Alae Kawam

I recently attended grand rounds at my institution and left inspired by the many ways artificial intelligence (AI) could transform our workflows. AI promises to enhance diagnostic precision and efficiency – by gathering information from patient charts, triaging cases, assisting with diagnoses, generating reports, and even handling administrative tasks such as billing.

I couldn’t help but feel excited by the idea of a shorter workday and a better balance between career and family life.

But is that how organizations perceive AI? Do they envision shorter workdays – or simply faster ones that enable more work? Are we setting ourselves up to deepen existing challenges like burnout? And what about the less tangible concerns: becoming obsolete as pathologists, or losing meaning in our work?

I try not to overthink these questions, but I suspect they’ll surface soon enough as AI becomes more deeply embedded in medicine. It’s better to begin understanding – and planning for – them now.

I don’t believe pathologists will become obsolete: our roles will evolve. I foresee a future where pathologists not only sign out cases with AI assistance but also act as co-creators of these systems. We’ll take part in validation studies, bias testing, and regulatory oversight. We’ll contribute more actively to epidemiological research and global health surveillance.

And meaning won’t disappear – it will shift. Pathologists will focus more on human-centered tasks: complex interpretation, clinical integration, communicating patient stories, mentoring, and leadership.

Still, organizations may have a different vision for AI. And that’s where tension could arise.

While pathologists might view AI as a tool to improve quality of life and enhance professional fulfillment, leadership may see it as a way to accelerate diagnostics and maximize productivity – potentially at the expense of wellbeing. If that happens, we risk worsening the very problems AI was meant to solve: burnout, turnover, and moral fatigue.

This friction – between organizational ambition and professional sustainability – can be avoided if both sides are clear about their expectations. AI should not be something imposed on pathologists, nor should it be something adopted by pathologists in isolation. Collaboration is essential.

The best path forward lies in shared intent and transparency. We must ask:

What do we truly want from AI?

How can we use it responsibly?

What outcomes do we expect – for our patients, our institutions, and ourselves?

There may not be simple answers. But asking the questions now ensures that as we build the future of pathology, we don’t forget the most important part of the work: being human.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Alae Kawam

Fellow in Genitourinary Pathology at Mt. Sinai Hospital, New York City, USA

More Articles by Alae Kawam

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Technology and innovation
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Opening a Window into Brain Trauma
Technology and innovation
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Molecular Spectacular
Technology and innovation
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Cracking Colon Cancer
Technology and innovation
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.